CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a synthetic biology company focused on the industrial biotechnology markets, today announced it has signed an agreement with Syngenta Biotechnology, Inc. Under the terms of the agreement, Verdezyne will synthesize novel genes, to be tested for optimized expression of enzymes in plants by Syngenta, using its unique technology platform.
